Chronic gastritis

被引:306
作者
Sipponen, Pentti
Maaroos, Heidi-Ingrid
机构
[1] Patolab Oy, Espoo, Finland
[2] Tartu State Univ, Tartu, Estonia
关键词
gastric cancer; gastritis; Helicobacter pylori; peptic ulcer; HELICOBACTER-PYLORI INFECTION; TERM-FOLLOW-UP; ATROPHIC GASTRITIS; INTESTINAL METAPLASIA; BODY GASTRITIS; SYDNEY SYSTEM; PEPTIC-ULCER; PERNICIOUS-ANEMIA; POPULATION-SAMPLE; PLASMA BIOMARKERS;
D O I
10.3109/00365521.2015.1019918
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Prevalence of chronic gastritis has markedly declined in developed populations during the past decades. However, chronic gastritis is still one of the most common serious pandemic infections with such severe killing sequelae as peptic ulcer or gastric cancer. Globally, on average, even more than half of people may have a chronic gastritis at present. Helicobacter pylori infection in childhood is the main cause of chronic gastritis, which microbial origin is the key for the understanding of the bizarre epidemiology and course of the disease. A life-long and aggressive inflammation in gastritis results in destruction (atrophic gastritis) of stomach mucosa with time (years and decades). The progressive worsening of atrophic gastritis results subsequently in dysfunctions of stomach mucosa. Atrophic gastritis will finally end up in a permanently acid-free stomach in the most extreme cases. Severe atrophic gastritis and acid-free stomach are the highest independent risk conditions for gastric cancer known so far. In addition to the risks of malignancy and peptic ulcer, acid-free stomach and severe forms of atrophic gastritis may associate with failures in absorption of essential vitamins, like vitamin B12, micronutrients (like iron, calcium, magnesium and zinc), diet and medicines.
引用
收藏
页码:657 / 667
页数:11
相关论文
共 84 条
[1]   Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers [J].
Agreus, Lars ;
Kuipers, Ernst J. ;
Kupcinskas, Limas ;
Malfertheiner, Peter ;
Di Mario, Francesco ;
Leja, Marcis ;
Mahachai, Varocha ;
Yaron, Niv ;
van Oijen, Martijn ;
Perez, Guillermo Perez ;
Rugge, Massimo ;
Ronkainen, Jukka ;
Salaspuro, Mikko ;
Sipponen, Pentti ;
Sugano, Kentaro ;
Sung, Joseph .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (02) :136-147
[2]   The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis [J].
Annibale, B ;
Di Giulio, E ;
Caruana, P ;
Lahner, E ;
Capurso, G ;
Bordi, C ;
Delle Fave, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) :1723-1731
[3]  
[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1
[4]   Helicobacter pylori eradication in the healing of atrophic gastritis:: A one-year prospective study [J].
Arkkila, PET ;
Seppälä, K ;
Färkkilä, MA ;
Veijola, L ;
Sipponen, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (07) :782-790
[5]  
Arkkila PET, 2003, AM J GASTROENTEROL, V98, P2149, DOI [10.1016/S0002-9270(03)00667-1, 10.1111/j.1572-0241.2003.07682.x]
[6]   HELICOBACTER-PYLORI THERAPY - EFFECT ON PEPTIC-ULCER DISEASE [J].
AXON, ATR .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (02) :131-137
[7]  
Axon ATR, 1995, ALIMENT PHARM THER, V9, P585
[8]  
Bolander-Gouaille Christina., 2002, Focus on Homocysteine and Vitamins Involved in its Metabolism
[9]  
CORREA P, 1988, AM J GASTROENTEROL, V83, P504
[10]  
CORREA P, 1990, CANCER RES, V50, P4737